Literature DB >> 34149081

Fish Oil Supplements for Prevention of Cardiovascular Disease: The Jury Is Still Out: CON: Fish Oil is Useful to Prevent or Treat Cardiovascular Disease.

Hekmat B Khoukaz1, William P Fay2.   

Abstract

Consumption of oily fish high in omega-3 fatty acids (n-3FAs) is strongly associated with reduced risk of adverse cardiovascular events. Eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) are the n-3FAs in fish oil believed to confer its beneficial effects. Over the past two decades, multiple clinical trials have been conducted to test the hypothesis that encapsulated EPA and DHA supplements improve cardiovascular outcomes in patients with established cardiovascular disease or at risk of developing it. Over the same time period, over-the-counter fish oil supplements have become a multi-billion-dollar industry. In this article, we briefly review available clinical trial data involving EPA and DHA supplementation. Based on currently available information, we conclude that combination capsules containing EPA and DHA should not be used to reduce cardiovascular risk. Some studies suggest that EPA as stand-alone therapy decreases cardiovascular risk. Nevertheless, we advocate a restrictive approach to using EPA to improve cardiovascular outcomes. Copyright 2021 by the Missouri State Medical Association.

Entities:  

Year:  2021        PMID: 34149081      PMCID: PMC8211000     

Source DB:  PubMed          Journal:  Mo Med        ISSN: 0026-6620


  40 in total

Review 1.  Cardiovascular effects of omega-3 fatty acids: Hope or hype?

Authors:  Sang-Ho Jo; Seung Hwan Han; Sang-Hyun Kim; Robert H Eckel; Kwang Kon Koh
Journal:  Atherosclerosis       Date:  2021-02-23       Impact factor: 5.162

2.  Plasma lipids and lipoproteins in Greenlandic west coast Eskimos.

Authors:  H O Bang; J Dyerberg
Journal:  Acta Med Scand       Date:  1972 Jul-Aug

Review 3.  Triglycerides and cardiovascular disease.

Authors:  Børge G Nordestgaard; Anette Varbo
Journal:  Lancet       Date:  2014-08-16       Impact factor: 79.321

4.  Hypertriglyceridemia as a cardiovascular risk factor.

Authors:  M A Austin; J E Hokanson; K L Edwards
Journal:  Am J Cardiol       Date:  1998-02-26       Impact factor: 2.778

5.  Effects of n-3 Fatty Acid Supplements in Diabetes Mellitus.

Authors:  Louise Bowman; Marion Mafham; Karl Wallendszus; Will Stevens; Georgina Buck; Jill Barton; Kevin Murphy; Theingi Aung; Richard Haynes; Jolyon Cox; Aleksandra Murawska; Allen Young; Michael Lay; Fang Chen; Emily Sammons; Emma Waters; Amanda Adler; Jonathan Bodansky; Andrew Farmer; Roger McPherson; Andrew Neil; David Simpson; Richard Peto; Colin Baigent; Rory Collins; Sarah Parish; Jane Armitage
Journal:  N Engl J Med       Date:  2018-08-26       Impact factor: 91.245

6.  Effect of High-Dose Omega-3 Fatty Acids vs Corn Oil on Major Adverse Cardiovascular Events in Patients at High Cardiovascular Risk: The STRENGTH Randomized Clinical Trial.

Authors:  Stephen J Nicholls; A Michael Lincoff; Michelle Garcia; Dianna Bash; Christie M Ballantyne; Philip J Barter; Michael H Davidson; John J P Kastelein; Wolfgang Koenig; Darren K McGuire; Dariush Mozaffarian; Paul M Ridker; Kausik K Ray; Brian G Katona; Anders Himmelmann; Larrye E Loss; Martin Rensfeldt; Torbjörn Lundström; Rahul Agrawal; Venu Menon; Kathy Wolski; Steven E Nissen
Journal:  JAMA       Date:  2020-12-08       Impact factor: 56.272

7.  The Anglo-Scandinavian Cardiac Outcomes Trial lipid lowering arm: extended observations 2 years after trial closure.

Authors:  Peter S Sever; Neil R Poulter; Bjorn Dahlof; Hans Wedel; Gareth Beevers; Mark Caulfield; Rory Collins; Sverre E Kjeldsen; Arni Kristinsson; Gordon McInnes; Jesper Mehlsen; Markku S Nieminen; Eoin T O'Brien; Jan Ostergren
Journal:  Eur Heart J       Date:  2008-01-05       Impact factor: 29.983

8.  MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial.

Authors: 
Journal:  Lancet       Date:  2002-07-06       Impact factor: 79.321

9.  Marine Omega-3 Supplementation and Cardiovascular Disease: An Updated Meta-Analysis of 13 Randomized Controlled Trials Involving 127 477 Participants.

Authors:  Yang Hu; Frank B Hu; JoAnn E Manson
Journal:  J Am Heart Assoc       Date:  2019-09-30       Impact factor: 5.501

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.